This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Epigenomics Ag. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Maxime P. Look: Innovator in Breast Cancer Research
Introduction
Maxime P. Look is an accomplished inventor based in Amsterdam, Netherlands, recognized for his significant contribution to breast cancer research. His work focuses on innovative methods to enhance the treatment and prediction of relapse for patients undergoing therapy.
Latest Patents
Maxime holds a notable patent titled "Method for determining risk of relapse of breast cancer following tamoxifen adjuvant therapy." This invention revolves around modified and genomic sequences, as well as oligonucleotides and/or PNA-oligomers designed to detect the cytosine methylation state of genomic DNA. Furthermore, it introduces a method for predicting how a patient with a cell proliferative disorder in breast tissues will respond to endocrine treatment.
Career Highlights
Maxime is a vital team member at Epigenomics AG, where he collaborates on research initiatives aimed at developing advanced treatments for cancer patients. His background in genetics and molecular biology equips him to tackle complex challenges in the field of cancer therapy.
Collaborations
During his career, Maxime has worked alongside esteemed colleagues such as John Foekens and Nadia Harbeck. Their collaborative efforts have furthered the understanding of cancer treatment and the mechanisms involved, contributing to advancements in personalized medicine.
Conclusion
Maxime P. Look's contributions to the field of breast cancer treatment exemplify the vital role inventors play in medical innovation. Through his patented methods and collaborative work, he continues to push the boundaries of what is possible in patient care and cancer research.